Fat Is a Matter? The Implication of Adipose Tissue in Cardiovascular Health and Disease

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Metabolism".

Deadline for manuscript submissions: 30 August 2024 | Viewed by 8179

Special Issue Editor


E-Mail Website
Guest Editor
Institute for Bio-Medical Convergence, College of Medicine, Catholic Kwandong University, Gangneung-si 210-701, Gangwon-do, Korea
Interests: stem cells; proteomics; transcriptomics; metabolic disease; ischemic heart; oxidative stress; obesity; diabetes; cell death

Special Issue Information

Dear Colleagues,

The adipose tissue in the human body can be generally divided into two main anatomical depots (visceral adipose tissue and subcutaneous adipose tissue) and is now recognized as an important regulator of cardiovascular health. Moreover, the interplay between the adipose tissue and the cardiovascular system is bidirectional, with vascular-derived and heart-derived signals directly affecting adipose tissue biology. Adipocytes play key roles in energy homeostasis throughout the body and can be classified as white adipocytes and brown adipocytes. More recently, the literature has suggested that white adipose tissue browning can be used as a novel therapeutic approach for treating cardiovascular and metabolic diseases. It has been indicated that epicardial fat functions similarly to brown adipocyte tissue and provides heat directly to the cardiac muscle. Thus, epicardial adipose tissue may protect the heart during core body temperature drops or protect the body from adverse hemodynamic conditions such as ischemia and hypoxia.

The aim of the Special Issue will be to focus on the study of adipose tissue (or adipocyte) function in cardiovascular health and disease. We invite all scientists working on adipose tissue function in disease to participate in this Special Issue. Original research articles, reviews, or shorter perspective articles on all aspects related to the molecular and cellular mechanisms of adipose tissue in health and disease. Articles with insights from a cell and molecular biological perspective are especially welcome.

Dr. Sang Woo Kim
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • adipose tissue
  • adipocyte
  • cardiovascular disease
  • metabolic disease
  • energy homeostasis

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

15 pages, 5072 KiB  
Article
Enhanced Osteocyte Differentiation: Cathepsin D and L Secretion by Human Adipose-Derived Mesenchymal Stem Cells
by Jung-Won Choi, Soyeon Lim, Seung Eun Jung, Seongtae Jeong, Hanbyeol Moon, Byeong-Wook Song, Il-Kwon Kim, Seahyoung Lee, Ki-Chul Hwang and Sang Woo Kim
Cells 2023, 12(24), 2852; https://doi.org/10.3390/cells12242852 - 17 Dec 2023
Viewed by 1010
Abstract
Adipose-derived mesenchymal stem cells (ASCs) have the potential to differentiate into bone, cartilage, fat, and neural cells and promote tissue regeneration and healing. It is known that they can have variable responses to hypoxic conditions. In the present study, we aimed to explore [...] Read more.
Adipose-derived mesenchymal stem cells (ASCs) have the potential to differentiate into bone, cartilage, fat, and neural cells and promote tissue regeneration and healing. It is known that they can have variable responses to hypoxic conditions. In the present study, we aimed to explore diverse changes in the cells and secretome of ASCs under a hypoxic environment over time and to present the possibility of ASCs as therapeutic agents from a different perspective. The expression differences of proteins between normoxic and hypoxic conditions (6, 12, or 24 h) were specifically investigated in human ASCs using 2-DE combined with MALDI-TOF MS analysis, and secreted proteins in ASC-derived conditioned media (ASC-derived CM) were examined by an adipokine array. In addition, genetic and/or proteomic interactions were assessed using a DAVID and miRNet functional annotation bioinformatics analysis. We found that 64 and 5 proteins were differentially expressed in hypoxic ASCs and in hypoxic ASC-derived CM, respectively. Moreover, 7 proteins among the 64 markedly changed spots in hypoxic ASCs were associated with bone-related diseases. We found that two proteins, cathepsin D (CTSD) and cathepsin L (CTSL), identified through an adipokine array independently exhibited significant efficacy in promoting osteocyte differentiation in bone-marrow-derived mesenchymal stem cells (BM-MSCs). This finding introduces a promising avenue for utilizing hypoxia-preconditioned ASC-derived CM as a potential therapeutic approach for bone-related diseases. Full article
Show Figures

Figure 1

19 pages, 11682 KiB  
Article
Brite Adipocyte FGF21 Attenuates Cardiac Ischemia/Reperfusion Injury in Rat Hearts by Modulating NRF2
by Hanbyeol Moon, Jung-Won Choi, Byeong-Wook Song, Il-Kwon Kim, Soyeon Lim, Seahyoung Lee, Gyoonhee Han, Ki-Chul Hwang and Sang Woo Kim
Cells 2022, 11(3), 567; https://doi.org/10.3390/cells11030567 - 06 Feb 2022
Cited by 5 | Viewed by 2696
Abstract
Although the optimal therapy for myocardial infarction includes reperfusion to restore blood flow to the ischemic area, myocardial injury after ischemia/reperfusion usually leads to an inflammatory response, oxidative stress, and cardiomyocyte apoptosis. In this study, rat adipose-derived stem cells were differentiated into low-thermogenic [...] Read more.
Although the optimal therapy for myocardial infarction includes reperfusion to restore blood flow to the ischemic area, myocardial injury after ischemia/reperfusion usually leads to an inflammatory response, oxidative stress, and cardiomyocyte apoptosis. In this study, rat adipose-derived stem cells were differentiated into low-thermogenic beige adipocytes (LBACs) and high-thermogenic beige adipocytes (HBACs) to study the different cardioprotective effects of heterogeneous expression of brown adipocytes. We found that antioxidant and antiapoptotic factors in H9c2 cardiomyocytes were upregulated by high levels of secreted FGF21 in HBAC conditioned medium (HBAC-CM), whereas FGF21 in HBAC-CM did not affect antioxidative or antiapoptotic cell death in H9c2 cardiomyocytes with Nrf2 knockdown. These results show that NRF2 mediates antioxidative and antiapoptotic effects through the HBAC-secreted factor FGF21. Consistent with this finding, the expression of antioxidant and antiapoptotic genes was upregulated by highly secreted FGF21 after HBAC-CM treatment compared to LBAC-CM treatment in H9c2 cardiomyocytes via NRF2 activation. Furthermore, HBAC-CM significantly attenuated ischemic rat heart tissue injury via NRF2 activation. Based on these findings, we propose that HBAC-CM exerts beneficial effects in rat cardiac ischemia/reperfusion injury by modulating NRF2 and has potential as a promising therapeutic agent for myocardial infarction. Full article
Show Figures

Graphical abstract

Review

Jump to: Research

21 pages, 1248 KiB  
Review
Role of Perivascular Adipose Tissue-Derived Adiponectin in Vascular Homeostasis
by Adrian Sowka and Pawel Dobrzyn
Cells 2021, 10(6), 1485; https://doi.org/10.3390/cells10061485 - 12 Jun 2021
Cited by 26 | Viewed by 3730
Abstract
Studies of adipose tissue biology have demonstrated that adipose tissue should be considered as both passive, energy-storing tissue and an endocrine organ because of the secretion of adipose-specific factors, called adipokines. Adiponectin is a well-described homeostatic adipokine with metabolic properties. It regulates whole-body [...] Read more.
Studies of adipose tissue biology have demonstrated that adipose tissue should be considered as both passive, energy-storing tissue and an endocrine organ because of the secretion of adipose-specific factors, called adipokines. Adiponectin is a well-described homeostatic adipokine with metabolic properties. It regulates whole-body energy status through the induction of fatty acid oxidation and glucose uptake. Adiponectin also has anti-inflammatory and antidiabetic properties, making it an interesting subject of biomedical studies. Perivascular adipose tissue (PVAT) is a fat depot that is conterminous to the vascular wall and acts on it in a paracrine manner through adipokine secretion. PVAT-derived adiponectin can act on the vascular wall through endothelial cells and vascular smooth muscle cells. The present review describes adiponectin’s structure, receptors, and main signaling pathways. We further discuss recent studies of the extent and nature of crosstalk between PVAT-derived adiponectin and endothelial cells, vascular smooth muscle cells, and atherosclerotic plaques. Furthermore, we argue whether adiponectin and its receptors may be considered putative therapeutic targets. Full article
Show Figures

Figure 1

Back to TopTop